Skip to main content

Cell-Free RNA Isolation and Extraction Kits Market Size, Global Trends, Latest Techniques, Key Segments And Forecasts Till 2032

Cell-Free RNA Isolation and Extraction Kits Market


 The market for cell-free RNA isolation and extraction kits is substantial and plays a crucial role in the gathering of data for a variety of treatment strategies, underscoring its importance in the healthcare industry. Since it ensures the safe and efficient use of targeted therapies, cell-free RNA is essential to the precision medicine approach. The majority of market participants in the global market for cell-free RNA isolation and extraction kits offer goods that include the kits.

The global cell-free RNA isolation and extraction kits market is projected to reach $140.7 million by 2032 from $30.2 million in 2021, growing at a CAGR of 14.98% during the forecast period 2022-2032. The growth in the cell-free RNA isolation and extraction kits market is expected to be driven by an increasing number of kits and a rising number of open-source free sequencing platform providers offering cell-free RNA analysis.

Cell-Free RNA Isolation and Extraction Kits Market

Impact

•   The presence of major products of cell-free RNA isolation and extraction kits in regions such as North America and APAC has a major impact on the market. For instance, QIAGEN N.V. provides cell-free RNA isolation and extraction kits.
•   Companies such as Zinexts Life Science Corp. and JBS Science, Inc. enter into a technology commercialization cooperation agreement to allow Zinexts to manufacture and sell JBS nucleic separation kits, including cfDNA and RNA isolation kits. This license agreement will make it easier to access JBS NA Zinexts's JBS NA isolation equipment as well as their isolation automation systems The presence of these companies has a positive impact on the market growth.

 

Recent Developments in Global Cell-Free RNA Isolation and Extraction Kits Market

•    In February 2022, Zinexts Life Science Corp. and JBS Science, Inc. enter into a technology commercialization cooperation agreement to allow Zinexts to manufacture and sell JBS nucleic separation kits, including cfDNA and RNA isolation kits. This license agreement will make it easier to access JBS NA Zinexts's JBS NA isolation equipment as well as their isolation automation systems.
•    In February 2019, Norgen Biotek Corp. introduced the cf-DNA / cf-RNA Preservative Tubes for long-term storage of blood. These are more suitable blood collection tubes (BCTs) as compared to other competitor’s blood collection tubes (BCTs) in the cell-free RNA market. This is the only product that keeps both cf-DNA and cf-RNA in the same tube for 30 days, allowing researchers to examine both genomics and transcriptomics.

 

Market Segmentation:

Cell-Free RNA Isolation and Extraction Kits Market

Segmentation 1: by Application
•    Oncology
•    Prenatal Screening (Preeclampsia)
•    Metabolic Disorders

The oncology segment accounted for the largest share of 79.85% in the global cell-free RNA isolation and extraction kits market in 2021.

 

Segmentation 2: by End User
•    Hospitals
•    Academic Research Institutions and Laboratories
•    Pharmaceutical and Biotechnology Companies
•    Diagnostic Laboratories

The academic research institutions and laboratories segment accounted for the largest share of 63.13% in the global cell-free RNA isolation and extraction kits market in FY2021.

Segmentation 3: by Region
•    North America
•    Europe
•    Asia-Pacific
•    Latin America
•    Rest-of-the-World

 

North America cell-free RNA isolation and extraction market dominated the global cell-free RNA isolation and extraction kits market and is expected to maintain its dominance over other regions throughout the forecast period 2022-2032.

Demand – Drivers and Limitations

Following are the demand drivers for the Global Cell-Free RNA Isolation and Extraction Kits Market:

•    Increasing Incidence of Cancer
•    Increasing Number of Cases with Prenatal Complications
•    Advancement in the RNA Sequencing Technology

The market is expected to face some limitations too due to the following challenges:

•    Lack of Skilled Professionals and Awareness Related to Cell-Free RNA Methods
•    Ethical, Legal, and Social Issues Associated with Prenatal Screening


Get Free Sample Report - https://bisresearch.com/requestsample?id=1355type=download


Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration.

The leading top segment players include cell-free RNA isolation and extraction kits manufacture in year 2021 that caters to different area of application that includes oncology, prenatal screening, and metabolic disorders.

Some of the prominent names established in this market are:

•    Aline Biosciences
•    Apostle Sciences
•    Danagen-Bioted, S.L.
•    F. Hoffmann-La Roche Ltd.
•    JBS Science Inc.
•    Norgen Biotek Corp.
•    PerkinElmer, Inc.
•    Promega Corporation
•    QIAGEN N.V.
•    Streck, Inc.
•    Thermo Fisher Scientific Inc.
•    Takara Bio Inc.
•    Zymo Research Corporation

Key Questions Answered in the Report

  • How is the cell-free RNA isolation and extraction kits
  • market revolutionizing oncology, prenatal screening, and metabolic disorders’ landscapes?
  • What are the major market drivers, challenges, and opportunities in the global cell-free RNA isolation and extraction kits market?
  • What are the underlying structures resulting in the emerging trends within the cell-free RNA isolation and extraction kits market?
  • What are the key development strategies that are being implemented by major players to sustain themselves in the market?
  • What are the key regulatory implications in developed and developing regions pertaining to the use of cell-free RNA products and services?

  USP of this report

• Extensive competitive benchmarking of the top 13 players has been done to offer a holistic view of the global cell-free RNA isolation and extraction kits market landscape 
• Market ranking analysis based on product portfolio, recent developments, and regional spread 
• Investment landscape including product adoption scenario, funding, and patent analysis

BIS Related Studies

Cell-Free DNA Isolation and Extraction Market - A Global and Regional Analysis

Global Nucleic Acid Isolation and Purification Market

Comments

Popular posts from this blog

Microbiome Therapeutics Market Growth, Segmentation, Opportunity and Forecast to 2032

  Global microbiome therapeutics market is expected to grow further in the coming years due to the continuous increase in awareness and need for better and safer treatment alternatives and the dominance of gastrointestinal (GI) and infectious diseases segment can be attributed to the existing dominance of microbiome therapeutics available for a variety of indications ranging from diarrhea and gut dysbiosis to skin disorders, cancer indications among others. The global microbiome therapeutics market which accounted for $306.3 million in 2021 is expected to reach $3,204 million by 2032, reporting a CAGR of 24.95% during the forecast period 2022-2032. The existing   microbiome therapeutics market    is favored by multiple factors, including the rising geriatric populations coupled with the increasing adoption of inorganic growth strategies by key players in the market. Impact of COVID-19 There were numerous consequences due to the COVID-19 pandemic, especially...

Ligase Market Opportunities, Strategies, Share, Segmentation, In-depth Analysis 2032

  The global ligase market is progressing rapidly with a significant increase in the research and development activities pertaining to a wide range of ligase product for disease detection, accentuating their criticality in healthcare. Ligase enzyme has a critical role in the molecular diagnostics approach, as it ensures the safe and effective application of targeted therapeutics. Most of the players in the global ligase market offer products encompassing the ligation kits and enzymes. The global  ligase market  is projected to reach $651.4 million by 2032 from $371.2 million in 2021, at a CAGR of 5.29% during the forecast period 2022-2032. The growth in the global ligase market is expected to be driven by factors such as the increasing prevalence of infectious and genetic diseases on a global level, rising awareness of enzyme based diagnostic testing and significant number of funding for executing research and development.   Impact Several techniques are employed in ...

PD-1/PDL-1 Inhibitor Market Growth Prospects, Emerging Trends and Forecast to 2032

  PD-1/PDL-1 inhibitors are immune-therapeutic agents used in the treatment of various cancer indications, mostly in the advanced stages. PD-1/PDL-1 inhibitors are monoclonal antibodies majorly of IgG1 and IgG4 types to be administered to patients via injection The current market already has seven approved products in the U.S. and a large number of research activities are currently undergoing in this segment generating interest of commercial as well as academic research institutions. In the current period of precision medicine and providing targeted treatment, identification of target patient has become very important as well as complicated. With the emergence of diagnostic test identifying predictive biomarkers, the selection and administration of targeted treatment has become comparativlely conveninent and efficient. PD-1/PDL-1 inhibitors market   are majorly indicated for the treatment of advanced cases of different cancer indications. The PD-1/PDL-1 inibitor treatment has ...